Overview

Non-interaction Study Between Pregabalin and Tramadol, Administered Individually or Combination, in Healthy Subjects

Status:
Completed
Trial end date:
2019-03-27
Target enrollment:
Participant gender:
Summary
The study was carried out in the Clinical Unit and Analytical Unit of the Department of Pharmacology and Toxicology of the Faculty of Medicine of the Universidad Autónoma de Nuevo León, with the aim of comparing the bioavailability (maximum concentration and area under the curve) of an oral formulation containing Pregabalin 150 mg/Tramadol 50 mg in combination with the two oral formulations Pregabalin 150 mg or Tramadol 50 mg administered as a single dose, in healthy subjects under fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Laboratorios Silanes S.A. de C.V.
Treatments:
Pregabalin
Tramadol